M. Franco G. Salvoza

Array ( [id] => 6931144 [patent_doc_number] => 20050282179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Biomarkers for interferon-alpha response in hepatitis C virus infected patients' [patent_app_type] => utility [patent_app_number] => 11/005881 [patent_app_country] => US [patent_app_date] => 2004-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21960 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282179.pdf [firstpage_image] =>[orig_patent_app_number] => 11005881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 727420 [patent_doc_number] => 07041299 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-09 [patent_title] => 'Escape mutants of newcastle disease virus as marker vaccines' [patent_app_type] => utility [patent_app_number] => 10/990204 [patent_app_country] => US [patent_app_date] => 2004-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7160 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/041/07041299.pdf [firstpage_image] =>[orig_patent_app_number] => 10990204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5188476 [patent_doc_number] => 20070166784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'Combination approaches for generating immune responses' [patent_app_type] => utility [patent_app_number] => 10/571882 [patent_app_country] => US [patent_app_date] => 2004-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 46193 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20070166784.pdf [firstpage_image] =>[orig_patent_app_number] => 10571882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5302909 [patent_doc_number] => 20090297561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'Method for vaccination of poultry by bacteriophage lysate bacterin' [patent_app_type] => utility [patent_app_number] => 11/658397 [patent_app_country] => US [patent_app_date] => 2004-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8563 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20090297561.pdf [firstpage_image] =>[orig_patent_app_number] => 11658397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 623496 [patent_doc_number] => 07138274 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-21 [patent_title] => 'Advanced oral poliovirus vaccine (Adv-OPV) deprived of the possibility of vaccine associated paralytic poliomyelities (VAPP)' [patent_app_type] => utility [patent_app_number] => 10/926333 [patent_app_country] => US [patent_app_date] => 2004-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 12170 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/138/07138274.pdf [firstpage_image] =>[orig_patent_app_number] => 10926333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7121997 [patent_doc_number] => 20050013826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Vaccine compositions and methods' [patent_app_type] => utility [patent_app_number] => 10/866484 [patent_app_country] => US [patent_app_date] => 2004-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11805 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20050013826.pdf [firstpage_image] =>[orig_patent_app_number] => 10866484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 432045 [patent_doc_number] => 07264818 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-04 [patent_title] => 'BAV packaging regions and E1 transcriptional control regions' [patent_app_type] => utility [patent_app_number] => 10/866505 [patent_app_country] => US [patent_app_date] => 2004-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 28 [patent_no_of_words] => 25512 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/264/07264818.pdf [firstpage_image] =>[orig_patent_app_number] => 10866505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7045519 [patent_doc_number] => 20050250114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Method for decreasing the number of free virus particles within the bodily fluids of a virally-infected mammal' [patent_app_type] => utility [patent_app_number] => 10/841746 [patent_app_country] => US [patent_app_date] => 2004-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1835 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20050250114.pdf [firstpage_image] =>[orig_patent_app_number] => 10841746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 455715 [patent_doc_number] => 07244435 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-17 [patent_title] => 'DNA vaccine expressing HA1 of equine-2 influenza virus' [patent_app_type] => utility [patent_app_number] => 10/826929 [patent_app_country] => US [patent_app_date] => 2004-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7281 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/244/07244435.pdf [firstpage_image] =>[orig_patent_app_number] => 10826929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 379995 [patent_doc_number] => 07309566 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-18 [patent_title] => 'Genetically biotinylated recombinant antibody in immunofiltration assay by light addressable potentiometric sensor for identification of Venezuelan equine encephalitis virus' [patent_app_type] => utility [patent_app_number] => 10/807194 [patent_app_country] => US [patent_app_date] => 2004-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4596 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/309/07309566.pdf [firstpage_image] =>[orig_patent_app_number] => 10807194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5700010 [patent_doc_number] => 20060216694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Use of a virus expressing a binding moiety to measure analytes in a sample' [patent_app_type] => utility [patent_app_number] => 10/548111 [patent_app_country] => US [patent_app_date] => 2004-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5791 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20060216694.pdf [firstpage_image] =>[orig_patent_app_number] => 10548111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7195452 [patent_doc_number] => 20050164167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Method of discovery and development of broad-spectrum antiviral drugs' [patent_app_type] => utility [patent_app_number] => 10/766226 [patent_app_country] => US [patent_app_date] => 2004-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 25463 [patent_no_of_claims] => 117 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20050164167.pdf [firstpage_image] =>[orig_patent_app_number] => 10766226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7345554 [patent_doc_number] => 20040247610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Composition and method for preventing or treating a virus infection' [patent_app_type] => new [patent_app_number] => 10/757692 [patent_app_country] => US [patent_app_date] => 2004-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7765 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20040247610.pdf [firstpage_image] =>[orig_patent_app_number] => 10757692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 686503 [patent_doc_number] => 07078218 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-18 [patent_title] => 'Alphavirus particles and methods for preparation' [patent_app_type] => utility [patent_app_number] => 10/734609 [patent_app_country] => US [patent_app_date] => 2003-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16986 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/078/07078218.pdf [firstpage_image] =>[orig_patent_app_number] => 10734609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7470878 [patent_doc_number] => 20040121444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Method of preparing recombinant adeno-associated virus compositions' [patent_app_type] => new [patent_app_number] => 10/731726 [patent_app_country] => US [patent_app_date] => 2003-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14379 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20040121444.pdf [firstpage_image] =>[orig_patent_app_number] => 10731726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7295062 [patent_doc_number] => 20040213808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Recombinant vaccine against flavivirus infection' [patent_app_type] => new [patent_app_number] => 10/730776 [patent_app_country] => US [patent_app_date] => 2003-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15325 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20040213808.pdf [firstpage_image] =>[orig_patent_app_number] => 10730776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7034219 [patent_doc_number] => 20050032729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Identification of oligonucleotides for the capture, detection and quantitation of West Nile virus' [patent_app_type] => utility [patent_app_number] => 10/729421 [patent_app_country] => US [patent_app_date] => 2003-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15037 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032729.pdf [firstpage_image] =>[orig_patent_app_number] => 10729421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 415055 [patent_doc_number] => 07279275 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-09 [patent_title] => 'Methods and compositions for detection of segmented negative strand RNA viruses' [patent_app_type] => utility [patent_app_number] => 10/700239 [patent_app_country] => US [patent_app_date] => 2003-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9011 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/279/07279275.pdf [firstpage_image] =>[orig_patent_app_number] => 10700239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7199654 [patent_doc_number] => 20040086534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Orally-administered interferon-tau compositions and methods' [patent_app_type] => new [patent_app_number] => 10/694247 [patent_app_country] => US [patent_app_date] => 2003-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11240 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20040086534.pdf [firstpage_image] =>[orig_patent_app_number] => 10694247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7287113 [patent_doc_number] => 20040147004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => '12832, a novel human kinase-like molecule and uses thereof' [patent_app_type] => new [patent_app_number] => 10/682739 [patent_app_country] => US [patent_app_date] => 2003-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 27423 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20040147004.pdf [firstpage_image] =>[orig_patent_app_number] => 10682739 [rel_patent_id] =>[rel_patent_doc_number] =>)